BCL2L11 and Miyoshi myopathy: Notably, it has been demonstrated that increased BATF expression improves sensitivity to venetoclax in HMCLs without changes in expression of BIM, BCL2, BCL2L1, or MCL1, thus suggesting that a BATF mediated transcriptional program may contribute to venetoclax response in MM [19].